Hana Yamamoto
Consumer Staples Analyst
Articles 760
Exploring Behavioral Science in Branding and Investing with MichaelAaron Flicker
Insights into Human Decision-Making, Loss Aversion, and Consumer Psychology
Behavioral science offers profound insights into consumer behavior and investment decisions, as examined in a discussion with MichaelAaron Flicker, co...
Developing a Robust Stock Trading Checklist: Your Step-by-Step Framework for Consistent and Disciplined Decisions
For beginner and intermediate traders looking to build and use structured trading checklists that improve decision-making and risk control
Trading checklists help bring clarity and discipline to your stock market decisions, reducing errors and emotional impulses. This comprehensive guide ...
Daisy Ridley Leads in 'We Bury the Dead,' a Zombie Thriller Exploring Loss and Survival
An apocalyptic disaster sets the stage for a haunting journey through grief and the unknown in Tasmania
In 'We Bury the Dead,' Daisy Ridley portrays Ava, a woman grappling with devastating loss after an experimental weapon causes mass casualties in Tasma...
Zuckerman Investment Group Expands Stake in Henry Schein Following Strong Quarterly Performance and Efficiency Initiative
Henry Schein demonstrates solid revenue growth and operational efficiency improvements amid sector challenges
Chicago-based Zuckerman Investment Group has increased its holdings in Henry Schein, underscoring confidence in the company's recent record quarterly ...
Alphabet: A Reliable Contender in AI Investment Over Risky Penny Stocks
Established technology giant Alphabet offers a comprehensive AI portfolio and financial strength, positioning it as a prudent long-term investment in artificial intelligence.
The excitement surrounding artificial intelligence has driven many investors toward high-risk penny stocks with uncertain futures. In contrast, Alphab...
Ultragenyx Pharmaceutical Plunges Amid Phase 3 Trial Setbacks; Market Sees Varied Stock Movements
Shares of Ultragenyx tumble 42% following Phase 3 study results, while other biotech and tech stocks show mixed performance
Ultragenyx Pharmaceutical's stock declined dramatically after clinical setbacks in pivotal Phase 3 trials for setrusumab, a treatment targeting Osteog...
Praxis Precision Medicines Advances Essential Tremor Treatment with FDA Breakthrough Designation
Ulixacaltamide's expedited development signals potential impact on multi-billion dollar essential tremor market
Praxis Precision Medicines Inc. saw a significant stock increase following the FDA's designation of its drug ulixacaltamide as a Breakthrough Therapy ...
Market Volatility Marks Decline in Silver Prices and Volatile Stock Movements Across Sectors
Silver Prices Retrace Gains Amid Mixed Performance in U.S. and Global Equity Markets
U.S. equity markets experienced declines across major indexes on Monday with the Nasdaq Composite dropping over 100 points. Precious metals including ...
Gold Experiences Temporary Retreat Following Historic Surge Amid Global Metal Supply Constraints
SPDR Gold Trust (AMEX:GLD) Retreats from Peak Prices as Structural Changes in Monetary Systems and Asian Market Dynamics Influence Precious Metals
The SPDR Gold Trust and spot gold prices recently attained unprecedented highs, noticeably crossing the $4,550 mark before retracting slightly due to ...
Gold Prices Retreat From Historic Highs Amid Structural Shifts in Global Finance
SPDR Gold Shares Edges Lower Following Peak in Metal Rally Driven by Asian Supply Crunch and Monetary Uncertainty
Gold prices recently surged to unprecedented levels, propelled by a significant supply shock and a transformation in the global financial landscape. A...